Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

for
Non-hematologic Cancer
Location: Boise ID
Sponsor: Sequenom, Inc.

Sex: All

Age: 18+

Code: NCT02586389

Recruiting

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Fairfax VA, Toronto,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

for
Neoplasms, Tenosynovial Giant Cell Tumor
Location: Beverly Hills CA
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT04192344

Phase 1, Recruiting

Cryopreservation of Ovarian Tissue

for
Cancer, Risk of Premature Ovarian Failure,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 0 - 45

Code: NCT01558544

Recruiting

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06810544

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Margate FL, San Antonio TX, Beverly Hills CA
Sponsor: Pyrotech Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06244992

Phase 1, Phase 2, Recruiting

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery

for
Prostate Cancer, Localized Malignant Neoplasm
Location: Washington DC
Sponsor: Georgetown University

Sex: Male

Age: 18 - 70+

Code: NCT01766492

Recruiting

INTERogating Cancer for Etiology, Prevention and Therapy Navigation

for
Cancer, Cancer Gene Mutation, PAN Gene Mutation,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06008392

Recruiting

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

for
Thyroid Eye Disease, Graves Orbitopathy,
Location: Miami FL, Morgantown WV
Sponsor: Sling Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06112340

Phase 2, Phase 3, Recruiting

Mindfulness in Endometrial and Cervical Cancer

for
Gynecologic Cancer, Endometrial Cancer, Cervical Cancer,
Location: St Louis MO
Sponsor: St. Louis University

Sex: Female

Age: 18 - 70+

Code: NCT04512144

Recruiting

Lurbinectedin in FET-Fused Tumors

for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Boston MA, New York NY, Philadelphia PA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10+

Code: NCT05918640

Phase 1, Phase 2, Recruiting

A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

for
Gynecologic Cancer, Post Operative Pain
Location: Abington PA
Sponsor: Abington Memorial Hospital

Sex: Female

Age: 18 - 70+

Code: NCT03304444

Phase 3, Recruiting

Synapse 3D With Intravascular Indocyanine Green

for
Non-small Cell Lung Cancer, Primary Neoplasm
Location: Hamilton
Sponsor: St. Joseph's Healthcare Hamilton

Sex: All

Age: 18+

Code: NCT03953144

Phase 1, Phase 2, Recruiting

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

for
Malignant Female Reproductive System Neoplasm
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: Female

Age: 0+

Code: NCT06525740

Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Lake Success NY, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06657144

Phase 1, Recruiting

Comprehensive Connected Cancer Care (C4): Intervention Evaluation

for
Cancer, Health Care Utilization
Location: Lexington KY
Sponsor: Timothy Mullett

Sex: All

Age: 18+

Code: NCT06326567

Recruiting

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

for
Cancer
Location: San Francisco CA
Sponsor: CellSight Technologies, Inc.

Sex: All

Age: 18 - 65

Code: NCT03142204

Phase 1, Recruiting

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

for
Neoplasms, Cancer, Caregiver
Location: Washington D.C. DC
Sponsor: Cancer Support Community, Research and Training Institute, Philadelphia

Sex: All

Age: 18+

Code: NCT02333604

Recruiting

A Five-Year Quality of Life Study for Cancer Patients

for
Cancer
Location: Grapevine TX
Sponsor: Constantine A. Kotsanis

Sex: All

Age: 18+

Code: NCT01539148

Recruiting

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: San Francisco CA
Sponsor: Robert Bok, MD, PhD

Sex: All

Age: 18+

Code: NCT05599048

Phase 1, Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial